We are live on
!
Find out more
BCM
Beryl Capital Management Portfolio holdings
AUM
$110M
1-Year Est. Return
317.92%
This Fund
S&P 500
This Quarter
Est. Return
+39.2%
1 Year Est. Return
+317.92%
3 Year Est. Return
+5,124.04%
5 Year Est. Return
+10,319.28%
10 Year Est. Return
–
AUM
$620M
AUM Growth
+$233M
(+60%)
Cap. Flow
+$153M
Cap. Flow
% of AUM
24.64%
Top 10 Holdings %
Top 10 Hldgs %
73.77%
Holding
70
New
41
Increased
5
Reduced
–
Closed
22
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$67.8M |
| 2 |
TIF
Tiffany & Co.
TIF
|
+$66.2M |
| 3 |
MDCO
Medicines Co
MDCO
|
+$47.5M |
| 4 |
INXN
Interxion Holding N.V.
INXN
|
+$37.9M |
| 5 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$29.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$91.5M |
| 2 |
BPL
Buckeye Partners, L.P.
BPL
|
+$87.9M |
| 3 |
CVRS
CORINDUS VASCULAR ROBOTICS, INC
CVRS
|
+$26.4M |
| 4 |
BID
Sotheby's
BID
|
+$22.6M |
| 5 |
TYPE
Monotype Imaging Holdings Inc.
TYPE
|
+$20.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.13% |
| 2 | Industrials | 8.99% |
| 3 | Technology | 7.25% |
| 4 | Communication Services | 6.38% |
| 5 | Energy | 6.21% |
Similar funds
BCM
NMC
NA
MCM
OWA
PXPO
FA
NC
Beryl Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Beryl Capital Management held 70 positions worth $620M, up 60% from $388M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Beryl Capital Management deployed $153M of net new capital in Q4 2019, opening 41 new positions and adding to 5 existing holdings. Its largest new stake was Tiffany & Co.: 559,900 shares worth $74.8M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 37% a quarter earlier, followed by Industrials and Technology.
On the sell side, the most notable exit was Celgene Corp, an estimated $91.5M sold.
- Beryl Capital Management's largest Q4 2019 buy was Tiffany & Co.: 559,900 shares worth $74.8M.
- Beryl Capital Management added most to Allergan plc in Q4 2019, an estimated $67.8M increase.
- Beryl Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $91.5M.
- Beryl Capital Management's ten largest holdings make up 74% of its $620M portfolio in Q4 2019.
- Beryl Capital Management opened 41 new positions and closed 22 in Q4 2019.
- Beryl Capital Management's portfolio value rose 60% quarter-over-quarter to $620M.
Based on Beryl Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.